Yes, the GLP-1 released from our intestinal cells is rapidly degraded, leading to low systemic levels, but its effects appear to be mediated by vagus nerve stimulation
PlexusDx recommends a focused, personalized approach: start with compounded tirzepatide (or an alternative GLP-1 agent suited to your genetic profile), optimize through your prescribing provider, and avoid additives unless directed by your medical team
In the case of metastatic breast cancer, combining ipilimumab and nivolumab with anthracycline-based chemotherapy leads to an escalation in toxic side effects without yielding any clinical benefits
Better circulation and cell migration can create a more active repair zone
Retatrutide will almost certainly fall in a similar range, possibly slightly higher given the additional receptor target and superior efficacy data